Annual report
9627.TEDINET S100U4ZX
Period2023-05-01 → 2024-04-30
Filed2024-07-31
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥399.8bn | 2023-05-01 → 2024-04-30 | Cons. | Net sales |
| Revenue | ¥358.7bn | 2022-05-01 → 2023-04-30 | Cons. | Net sales |
| Revenue | ¥316.2bn | 2021-05-01 → 2022-04-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥297.3bn | 2020-05-01 → 2021-04-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥292.6bn | 2019-05-01 → 2020-04-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥20.4bn | 2023-05-01 → 2024-04-30 | Cons. | Operating income |
| Operating income | ¥16.0bn | 2022-05-01 → 2023-04-30 | Cons. | Operating income |
| Ordinary income | ¥21.4bn | 2023-05-01 → 2024-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.1bn | 2022-05-01 → 2023-04-30 | Cons. | Ordinary income |
| Ordinary income | ¥16.0bn | 2021-05-01 → 2022-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.6bn | 2020-05-01 → 2021-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥16.8bn | 2019-05-01 → 2020-04-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥19.1bn | 2023-05-01 → 2024-04-30 | Cons. | Income before income taxes |
| Profit before tax | ¥15.9bn | 2022-05-01 → 2023-04-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥11.4bn | 2023-05-01 → 2024-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥9.2bn | 2022-05-01 → 2023-04-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥7.1bn | 2021-05-01 → 2022-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.7bn | 2020-05-01 → 2021-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.2bn | 2019-05-01 → 2020-04-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥11.4bn | 2023-05-01 → 2024-04-30 | Cons. | Profit loss |
| Net income | ¥9.2bn | 2022-05-01 → 2023-04-30 | Cons. | Profit loss |
| Total assets | ¥249.4bn | at 2024-04-30 | Cons. | Assets |
| Total assets | ¥231.8bn | at 2023-04-30 | Cons. | Assets |
| Total assets | ¥212.5bn | at 2022-04-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥203.7bn | at 2021-04-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥193.5bn | at 2020-04-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥114.0bn | at 2024-04-30 | Cons. | Liabilities |
| Total liabilities | ¥105.2bn | at 2023-04-30 | Cons. | Liabilities |
| Net assets / equity | ¥135.4bn | at 2024-04-30 | Cons. | Net assets |
| Net assets / equity | ¥126.5bn | at 2023-04-30 | Cons. | Net assets |
| Net assets / equity | ¥119.0bn | at 2022-04-30d | Cons. | Net assets |
| Net assets / equity | ¥115.8bn | at 2021-04-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥111.0bn | at 2020-04-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥48.6bn | at 2024-04-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥46.8bn | at 2023-04-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥48.4bn | at 2024-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.2bn | at 2023-04-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥59.5bn | at 2022-04-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥55.0bn | at 2021-04-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥45.9bn | at 2020-04-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥23.0bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥20.3bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥26.2bn | 2021-05-01 → 2022-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.9bn | 2020-05-01 → 2021-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥17.7bn | 2019-05-01 → 2020-04-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥15.7bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥22.3bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥13.9bn | 2021-05-01 → 2022-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥9.5bn | 2020-05-01 → 2021-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥11.5bn | 2019-05-01 → 2020-04-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.1bn | 2023-05-01 → 2024-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥11.2bn | 2022-05-01 → 2023-04-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥7.8bn | 2021-05-01 → 2022-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.6bn | 2020-05-01 → 2021-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥7.8bn | 2019-05-01 → 2020-04-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥324.64 | 2023-05-01 → 2024-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.87 | 2022-05-01 → 2023-04-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥201.47 | 2021-05-01 → 2022-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥189.04 | 2020-05-01 → 2021-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥259.11 | 2019-05-01 → 2020-04-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥3,866.55 | at 2024-04-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,599.47 | at 2023-04-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,385.51 | at 2022-04-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,267.49 | at 2021-04-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,130.77 | at 2020-04-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 54.3% | at 2024-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.6% | at 2023-04-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.8% | at 2021-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.3% | at 2020-04-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.7% | 2023-05-01 → 2024-04-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.5% | 2022-05-01 → 2023-04-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2021-05-01 → 2022-04-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-05-01 → 2021-04-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-05-01 → 2020-04-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 11,474 | at 2024-04-30 | Cons. | Number of employees |
| Employees | 10,651 | at 2023-04-30 | Cons. | Number of employees |
| Employees | 9,568 | at 2022-04-30d | Cons. | Number of employees |
| Employees | 9,019 | at 2021-04-30d | Cons. | Number of employees |
| Employees | 8,406 | at 2020-04-30d | Cons. | Number of employees |
| Revenue | ¥14.1bn | 2023-05-01 → 2024-04-30 | Standalone | Operating revenue1 |
| Revenue | ¥12.8bn | 2022-05-01 → 2023-04-30 | Standalone | Operating revenue1 |
| Revenue | ¥11.5bn | 2021-05-01 → 2022-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥11.6bn | 2020-05-01 → 2021-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥10.3bn | 2019-05-01 → 2020-04-30d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥5.1bn | 2023-05-01 → 2024-04-30 | Standalone | Operating income |
| Operating income | ¥4.7bn | 2022-05-01 → 2023-04-30 | Standalone | Operating income |
| Ordinary income | ¥5.3bn | 2023-05-01 → 2024-04-30 | Standalone | Ordinary income |
| Ordinary income | ¥5.0bn | 2022-05-01 → 2023-04-30 | Standalone | Ordinary income |
| Ordinary income | ¥5.2bn | 2021-05-01 → 2022-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.3bn | 2020-05-01 → 2021-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥5.8bn | 2019-05-01 → 2020-04-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥5.1bn | 2023-05-01 → 2024-04-30 | Standalone | Income before income taxes |
| Profit before tax | ¥5.0bn | 2022-05-01 → 2023-04-30 | Standalone | Income before income taxes |
| Net income | ¥4.9bn | 2023-05-01 → 2024-04-30 | Standalone | Profit loss |
| Net income | ¥4.9bn | 2022-05-01 → 2023-04-30 | Standalone | Profit loss |
| Net income | ¥5.0bn | 2021-05-01 → 2022-04-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥6.1bn | 2020-05-01 → 2021-04-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥5.5bn | 2019-05-01 → 2020-04-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥146.2bn | at 2024-04-30 | Standalone | Assets |
| Total assets | ¥143.8bn | at 2023-04-30 | Standalone | Assets |
| Total assets | ¥140.2bn | at 2022-04-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥136.4bn | at 2021-04-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥121.3bn | at 2020-04-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥62.7bn | at 2024-04-30 | Standalone | Liabilities |
| Total liabilities | ¥62.5bn | at 2023-04-30 | Standalone | Liabilities |
| Net assets / equity | ¥83.5bn | at 2024-04-30 | Standalone | Net assets |
| Net assets / equity | ¥81.3bn | at 2023-04-30 | Standalone | Net assets |
| Net assets / equity | ¥78.2bn | at 2022-04-30d | Standalone | Net assets |
| Net assets / equity | ¥77.3bn | at 2021-04-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥73.0bn | at 2020-04-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥34.0bn | at 2024-04-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥30.2bn | at 2023-04-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥140.65 | 2023-05-01 → 2024-04-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥139.46 | 2022-05-01 → 2023-04-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥141.15 | 2021-05-01 → 2022-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥172.16 | 2020-05-01 → 2021-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥154.31 | 2019-05-01 → 2020-04-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥80 | 2023-05-01 → 2024-04-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2022-05-01 → 2023-04-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2021-05-01 → 2022-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2020-05-01 → 2021-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥55 | 2019-05-01 → 2020-04-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥2,386.57 | at 2024-04-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,313.07 | at 2023-04-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,227.25 | at 2022-04-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,180.74 | at 2021-04-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥2,061.88 | at 2020-04-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 57.1% | at 2024-04-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.5% | at 2023-04-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.8% | at 2022-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.6% | at 2021-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.2% | at 2020-04-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.0% | 2023-05-01 → 2024-04-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.1% | 2022-05-01 → 2023-04-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.4% | 2021-05-01 → 2022-04-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.1% | 2020-05-01 → 2021-04-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.7% | 2019-05-01 → 2020-04-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 35,428,212 | at 2024-04-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2023-04-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2022-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2021-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 35,428,212 | at 2020-04-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 162 | at 2024-04-30 | Standalone | Number of employees |
| Employees | 161 | at 2023-04-30 | Standalone | Number of employees |
| Employees | 160 | at 2022-04-30d | Standalone | Number of employees |
| Employees | 156 | at 2021-04-30d | Standalone | Number of employees |
| Employees | 151 | at 2020-04-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 66
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | capex | 2023-05-01 → 2024-04-30 | ¥1.0bn |
| Otherother segments | depreciation | 2023-05-01 → 2024-04-30 | ¥279m |
| Otherother segments | revenue | 2023-05-01 → 2024-04-30 | ¥11.2bn |
| Otherother segments | revenue external | 2023-05-01 → 2024-04-30 | ¥11.1bn |
| Otherother segments | revenue intersegment | 2023-05-01 → 2024-04-30 | ¥54m |
| Otherother segments | segment assets | at 2024-04-30 | ¥10.4bn |
| Otherother segments | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥47m |
| Reconciling Itemsreconciling | capex | 2023-05-01 → 2024-04-30 | ¥2.3bn |
| Reconciling Itemsreconciling | depreciation | 2023-05-01 → 2024-04-30 | ¥1.0bn |
| Reconciling Itemsreconciling | revenue | 2023-05-01 → 2024-04-30 | −¥54m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-05-01 → 2024-04-30 | −¥54m |
| Reconciling Itemsreconciling | segment assets | at 2024-04-30 | ¥3.9bn |
| Reconciling Itemsreconciling | segment ordinary income | 2023-05-01 → 2024-04-30 | −¥9.4bn |
| Dispensing Pharmacyreportable segment | capex | 2023-05-01 → 2024-04-30 | ¥8.0bn |
| Dispensing Pharmacyreportable segment | depreciation | 2023-05-01 → 2024-04-30 | ¥3.7bn |
| Dispensing Pharmacyreportable segment | employees | at 2024-04-30 | 10440 pure |
| Dispensing Pharmacyreportable segment | revenue | 2023-05-01 → 2024-04-30 | ¥357.6bn |
| Dispensing Pharmacyreportable segment | revenue external | 2023-05-01 → 2024-04-30 | ¥357.6bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2024-04-30 | ¥219.7bn |
| Dispensing Pharmacyreportable segment | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥27.6bn |
| Drug And Cosmetic Storereportable segment | capex | 2023-05-01 → 2024-04-30 | ¥1.4bn |
| Drug And Cosmetic Storereportable segment | depreciation | 2023-05-01 → 2024-04-30 | ¥438m |
| Drug And Cosmetic Storereportable segment | employees | at 2024-04-30 | 582 pure |
| Drug And Cosmetic Storereportable segment | revenue | 2023-05-01 → 2024-04-30 | ¥31.1bn |
| Drug And Cosmetic Storereportable segment | revenue external | 2023-05-01 → 2024-04-30 | ¥31.1bn |
| Drug And Cosmetic Storereportable segment | segment assets | at 2024-04-30 | ¥15.4bn |
| Drug And Cosmetic Storereportable segment | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥3.1bn |
| —segment total | capex | 2023-05-01 → 2024-04-30 | ¥10.5bn |
| —segment total | depreciation | 2023-05-01 → 2024-04-30 | ¥4.4bn |
| —segment total | revenue | 2023-05-01 → 2024-04-30 | ¥399.9bn |
| —segment total | revenue external | 2023-05-01 → 2024-04-30 | ¥399.8bn |
| —segment total | revenue intersegment | 2023-05-01 → 2024-04-30 | ¥54m |
| —segment total | segment assets | at 2024-04-30 | ¥245.5bn |
| —segment total | segment ordinary income | 2023-05-01 → 2024-04-30 | ¥30.7bn |
| Otherother segments | capex | 2022-05-01 → 2023-04-30 | ¥1.0bn |
| Otherother segments | depreciation | 2022-05-01 → 2023-04-30 | ¥232m |
| Otherother segments | revenue | 2022-05-01 → 2023-04-30 | ¥11.5bn |
| Otherother segments | revenue external | 2022-05-01 → 2023-04-30 | ¥11.5bn |
| Otherother segments | revenue intersegment | 2022-05-01 → 2023-04-30 | ¥61m |
| Otherother segments | segment assets | at 2023-04-30 | ¥9.6bn |
| Otherother segments | segment ordinary income | 2022-05-01 → 2023-04-30 | ¥135m |
| Reconciling Itemsreconciling | capex | 2022-05-01 → 2023-04-30 | ¥2.0bn |
| Reconciling Itemsreconciling | depreciation | 2022-05-01 → 2023-04-30 | ¥767m |
| Reconciling Itemsreconciling | revenue | 2022-05-01 → 2023-04-30 | −¥61m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-05-01 → 2023-04-30 | −¥61m |
| Reconciling Itemsreconciling | segment assets | at 2023-04-30 | ¥13.2bn |
| Reconciling Itemsreconciling | segment ordinary income | 2022-05-01 → 2023-04-30 | −¥8.4bn |
| Dispensing Pharmacyreportable segment | capex | 2022-05-01 → 2023-04-30 | ¥8.3bn |
| Dispensing Pharmacyreportable segment | depreciation | 2022-05-01 → 2023-04-30 | ¥3.1bn |
| Dispensing Pharmacyreportable segment | revenue | 2022-05-01 → 2023-04-30 | ¥321.6bn |
| Dispensing Pharmacyreportable segment | revenue external | 2022-05-01 → 2023-04-30 | ¥321.6bn |
| Dispensing Pharmacyreportable segment | segment assets | at 2023-04-30 | ¥195.3bn |
| Dispensing Pharmacyreportable segment | segment ordinary income | 2022-05-01 → 2023-04-30 | ¥24.1bn |
| Drug And Cosmetic Storereportable segment | capex | 2022-05-01 → 2023-04-30 | ¥551m |
| Drug And Cosmetic Storereportable segment | depreciation | 2022-05-01 → 2023-04-30 | ¥426m |
| Drug And Cosmetic Storereportable segment | revenue | 2022-05-01 → 2023-04-30 | ¥25.7bn |
| Drug And Cosmetic Storereportable segment | revenue external | 2022-05-01 → 2023-04-30 | ¥25.7bn |
| Drug And Cosmetic Storereportable segment | segment assets | at 2023-04-30 | ¥13.6bn |
| Drug And Cosmetic Storereportable segment | segment ordinary income | 2022-05-01 → 2023-04-30 | ¥1.2bn |
| —segment total | capex | 2022-05-01 → 2023-04-30 | ¥9.9bn |
| —segment total | depreciation | 2022-05-01 → 2023-04-30 | ¥3.8bn |
| —segment total | revenue | 2022-05-01 → 2023-04-30 | ¥358.8bn |
| —segment total | revenue external | 2022-05-01 → 2023-04-30 | ¥358.7bn |
| —segment total | revenue intersegment | 2022-05-01 → 2023-04-30 | ¥61m |
| —segment total | segment assets | at 2023-04-30 | ¥218.6bn |
| —segment total | segment ordinary income | 2022-05-01 → 2023-04-30 | ¥25.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,628
| Item | Context | Value | Unit |
|---|---|---|---|
| Goodwill | Prior1YearInstant | 46443000000 | JPY |
| Amortization of goodwill segment information | CurrentYearDuration_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember | 4274000000 | JPY |
| Amortization of goodwill segment information | CurrentYearDuration_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember | 5000000 | JPY |
| Amortization of goodwill segment information | CurrentYearDuration_OtherReportableSegmentsMember | 140000000 | JPY |
| Amortization of goodwill segment information | CurrentYearDuration_UnallocatedAmountsAndEliminationMember | - | JPY |
| Amortization of goodwill segment information | CurrentYearDuration | 4421000000 | JPY |
| Goodwill | CurrentYearInstant_jpcrp030000-asr_E04896-000DispensingPharmacyReportableSegmentsMember | 43306000000 | JPY |
| Goodwill | CurrentYearInstant_jpcrp030000-asr_E04896-000DrugAndCosmeticStoreReportableSegmentsMember | - | JPY |
| Goodwill | CurrentYearInstant_OtherReportableSegmentsMember | 760000000 | JPY |
| Goodwill | CurrentYearInstant_UnallocatedAmountsAndEliminationMember | - | JPY |
| Goodwill | CurrentYearInstant | 44066000000 | JPY |
| Cash and deposits | Prior1YearInstant_NonConsolidatedMember | 30159000000 | JPY |
| Cash and deposits | CurrentYearInstant_NonConsolidatedMember | 33975000000 | JPY |
| Prepaid expenses | Prior1YearInstant_NonConsolidatedMember | 668000000 | JPY |
| Prepaid expenses | CurrentYearInstant_NonConsolidatedMember | 1024000000 | JPY |
| Short term loans receivable | Prior1YearInstant_NonConsolidatedMember | 14632000000 | JPY |
| Short term loans receivable | CurrentYearInstant_NonConsolidatedMember | 10898000000 | JPY |
| Accounts receivable other | Prior1YearInstant_NonConsolidatedMember | 1797000000 | JPY |
| Accounts receivable other | CurrentYearInstant_NonConsolidatedMember | 1893000000 | JPY |
| Other ca | Prior1YearInstant_NonConsolidatedMember | 2000000 | JPY |
| Other ca | CurrentYearInstant_NonConsolidatedMember | 0 | JPY |
| Current assets | Prior1YearInstant_NonConsolidatedMember | 47260000000 | JPY |
| Current assets | CurrentYearInstant_NonConsolidatedMember | 47792000000 | JPY |
| Buildings net | Prior1YearInstant_NonConsolidatedMember | 819000000 | JPY |
| Buildings net | CurrentYearInstant_NonConsolidatedMember | 1345000000 | JPY |
| Structures net | Prior1YearInstant_NonConsolidatedMember | 4000000 | JPY |
| Structures net | CurrentYearInstant_NonConsolidatedMember | 3000000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant_NonConsolidatedMember | 89000000 | JPY |
| Tools furniture and fixtures net | CurrentYearInstant_NonConsolidatedMember | 73000000 | JPY |
| Land | Prior1YearInstant_NonConsolidatedMember | 730000000 | JPY |
| Land | CurrentYearInstant_NonConsolidatedMember | 730000000 | JPY |
| Other net ppe | Prior1YearInstant_NonConsolidatedMember | 34000000 | JPY |
| Other net ppe | CurrentYearInstant_NonConsolidatedMember | 337000000 | JPY |
| Property plant and equipment | Prior1YearInstant_NonConsolidatedMember | 1676000000 | JPY |
| Property plant and equipment | CurrentYearInstant_NonConsolidatedMember | 2491000000 | JPY |
| Right of trademark | Prior1YearInstant_NonConsolidatedMember | 123000000 | JPY |
| Right of trademark | CurrentYearInstant_NonConsolidatedMember | 72000000 | JPY |
| Software | Prior1YearInstant_NonConsolidatedMember | 2398000000 | JPY |
| Software | CurrentYearInstant_NonConsolidatedMember | 3433000000 | JPY |
| Other ia | Prior1YearInstant_NonConsolidatedMember | 872000000 | JPY |
| Other ia | CurrentYearInstant_NonConsolidatedMember | 913000000 | JPY |
| Intangible assets | Prior1YearInstant_NonConsolidatedMember | 3394000000 | JPY |
| Intangible assets | CurrentYearInstant_NonConsolidatedMember | 4419000000 | JPY |
| Investment securities | Prior1YearInstant_NonConsolidatedMember | 2087000000 | JPY |
| Investment securities | CurrentYearInstant_NonConsolidatedMember | 2524000000 | JPY |
| Stocks of subsidiaries and affiliates | Prior1YearInstant_NonConsolidatedMember | 83625000000 | JPY |
| Stocks of subsidiaries and affiliates | CurrentYearInstant_NonConsolidatedMember | 83972000000 | JPY |
| Deferred tax assets | Prior1YearInstant_NonConsolidatedMember | 1202000000 | JPY |
| Deferred tax assets | CurrentYearInstant_NonConsolidatedMember | 1114000000 | JPY |
| Lease and guarantee deposits | Prior1YearInstant_NonConsolidatedMember | 3954000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |